As a leading supplier, Loncom Pharma's Levobupivacaine HCl APIs are a preferred choice for surgeries requiring local anesthesia due to their prolonged duration of action and lower cardiotoxicity compared to other local anesthetics. These APIs embody the synthesis of safety, efficacy, and quality, reflecting Loncom Pharma's rigorous standards and commitment to advancing patient care in surgical settings.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
